These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3092306

  • 1. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR, Bathras JM.
    Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [Abstract] [Full Text] [Related]

  • 2. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR, Augustine NH, Shigeoka AO.
    Am J Med; 1984 Mar 30; 76(3A):61-6. PubMed ID: 6424458
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD, Bathras JM, Shigeoka AO, James J, Pincus SH, Hill HR.
    J Infect Dis; 1989 Apr 30; 159(4):701-7. PubMed ID: 2494269
    [Abstract] [Full Text] [Related]

  • 4. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND, Munro CS, Cole PJ.
    Clin Exp Immunol; 1989 Apr 30; 76(1):8-12. PubMed ID: 2500275
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae].
    Mancilla-Ramírez J, Nurko-Shein S, Castellanos-Cruz C, Santos-Preciado JI.
    Bol Med Hosp Infant Mex; 1989 Feb 30; 46(2):89-93. PubMed ID: 2496700
    [Abstract] [Full Text] [Related]

  • 6. Safety and toxicity of a new serum immunoglobulin G intravenous preparation, IGIV pH 4.25.
    Pirofsky B.
    Rev Infect Dis; 1986 Feb 30; 8 Suppl 4():S457-63. PubMed ID: 3092311
    [Abstract] [Full Text] [Related]

  • 7. Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat.
    Emerson TE, Collins MS, Budinger MD.
    Rev Infect Dis; 1986 Feb 30; 8 Suppl 4():S409-19. PubMed ID: 3092308
    [Abstract] [Full Text] [Related]

  • 8. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW, Wilson SR, Hunter KW.
    J Clin Immunol; 1982 Apr 30; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [Abstract] [Full Text] [Related]

  • 9. Opsonic and complement-dependent bactericidal activities of various immunoglobulin preparations for intravenous use.
    Yasuda H, Yajima T, Tanii T, Ashiba T, Iwata M.
    Vox Sang; 1986 Apr 30; 51(4):270-7. PubMed ID: 3099470
    [Abstract] [Full Text] [Related]

  • 10. Three generations of immunoglobulin G preparations for clinical use.
    McCue JP, Hein RH, Tenold R.
    Rev Infect Dis; 1986 Apr 30; 8 Suppl 4():S374-81. PubMed ID: 3092303
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo activities of different immunoglobulin G preparations from the rabbit against Enterobacteriaceae.
    Trautmann M, Müller-Leutloff Y, Hofstaetter T, Seiler FR, Hahn H.
    Vox Sang; 1985 Apr 30; 49(4):267-76. PubMed ID: 4060694
    [Abstract] [Full Text] [Related]

  • 12. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R, Fischer GW.
    Pediatr Res; 1986 Feb 30; 20(2):175-8. PubMed ID: 3511443
    [Abstract] [Full Text] [Related]

  • 13. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
    Collins MS, Roby RE.
    J Trauma; 1983 Jun 30; 23(6):530-4. PubMed ID: 6408266
    [Abstract] [Full Text] [Related]

  • 14. Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE, Small GJ, Lostrom ME, Pier GB.
    Infect Immun; 1986 Oct 30; 54(1):239-44. PubMed ID: 3093385
    [Abstract] [Full Text] [Related]

  • 15. Opsonic antibodies of healthy human sera against some opportunistic pathogens.
    Arai T, Komatsu S, Ullah A.
    Kitasato Arch Exp Med; 1983 Sep 30; 56(3):63-71. PubMed ID: 6431174
    [No Abstract] [Full Text] [Related]

  • 16. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
    Teschner W, Butterweck HA, Auer W, Muchitsch EM, Weber A, Liu SL, Wah PS, Schwarz HP.
    Vox Sang; 2007 Jan 30; 92(1):42-55. PubMed ID: 17181590
    [Abstract] [Full Text] [Related]

  • 17. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV, Giebink GS.
    J Lab Clin Med; 1984 Dec 30; 104(6):977-86. PubMed ID: 6502004
    [Abstract] [Full Text] [Related]

  • 18. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF, Yang KD, Bohnsack JF, Hill HR.
    Pediatr Res; 1989 Jun 30; 25(6):634-40. PubMed ID: 2662129
    [Abstract] [Full Text] [Related]

  • 19. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS, Kang JH, Cross AS, Kaufman B, Zollinger W, Sadoff J.
    J Infect Dis; 1988 Jan 30; 157(1):47-53. PubMed ID: 2447199
    [Abstract] [Full Text] [Related]

  • 20. Antibody levels in reduced/alkylated intravenous immune globulin.
    Rousell RH, Collins MS, Dobkin MB, Louie RE, Roby RE, Sweet BH.
    Am J Med; 1984 Mar 30; 76(3A):40-5. PubMed ID: 6424456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.